BIODELIVERY SCIENCES INTL IN's ticker is BDSI and the CUSIP is 09060J106. A total of 154 filers reported holding BIODELIVERY SCIENCES INTL IN in Q1 2021. The put-call ratio across all filers is 0.73 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $1,581,000 | -66.1% | 376,363 | -69.9% | 0.20% | -66.1% |
| Q3 2020 | $4,670,000 | -13.2% | 1,252,079 | +1.4% | 0.59% | -15.8% |
| Q2 2020 | $5,382,000 | +24.6% | 1,234,501 | +8.3% | 0.70% | -1.7% |
| Q1 2020 | $4,319,000 | +148.5% | 1,139,701 | +314.5% | 0.71% | +289.6% |
| Q4 2019 | $1,738,000 | -45.6% | 274,945 | -63.7% | 0.18% | -45.0% |
| Q3 2019 | $3,193,000 | -1.9% | 758,462 | +8.3% | 0.33% | +3.7% |
| Q2 2019 | $3,256,000 | +107.5% | 700,159 | +136.5% | 0.32% | +111.2% |
| Q1 2019 | $1,569,000 | +88.4% | 296,039 | +31.5% | 0.15% | +83.1% |
| Q4 2018 | $833,000 | -86.8% | 225,201 | -82.9% | 0.08% | -70.1% |
| Q4 2015 | $6,297,000 | -8.0% | 1,314,623 | +6.8% | 0.28% | -22.8% |
| Q3 2015 | $6,842,000 | -41.7% | 1,230,592 | -16.5% | 0.36% | -25.6% |
| Q2 2015 | $11,737,000 | -2.3% | 1,474,528 | +28.9% | 0.48% | +2.1% |
| Q1 2015 | $12,013,000 | – | 1,144,101 | – | 0.47% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HealthInvest Partners AB | 1,575,000 | $6,615,000 | 4.38% |
| 1492 Capital Management LLC | 790,863 | $3,322,000 | 1.91% |
| Rubric Capital Management LP | 3,516,124 | $14,768,000 | 1.08% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 9,530,000 | $40,026,000 | 0.79% |
| Zebra Capital Management LLC | 144,241 | $606,000 | 0.77% |
| KNOTT DAVID M | 370,230 | $1,555,000 | 0.70% |
| Nantahala Capital Management | 5,123,671 | $21,519,000 | 0.67% |
| SYSTEMATIC FINANCIAL MANAGEMENT LP | 3,593,893 | $15,094,000 | 0.66% |
| EMC Capital Management | 98,933 | $416,000 | 0.32% |
| ALGERT GLOBAL LLC | 175,170 | $736,000 | 0.21% |